Updates are available Correction dated 2024-06-27

Article History

Received: 18 January 2024

Accepted: 15 April 2024

First Online: 6 May 2024

Change Date: 27 June 2024

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1186/s13063-024-08257-9

Declarations

:

: The data protection officer, Innlandet Hospital Trust, has approved the trial applications (case number: 23928741). The collected data from the sampled patients will be deidentified and stored on a secured research server at Innlandet Hospital Trust. Participants with the capacity to provide consent will be asked to give their written consent. For patients considered to lack the capacity to consent, the next of kin will be informed about the research and asked to provide consent on the patient’s behalf. Consent implies an understanding of what it means to participate in the RCT and the ability to express an informed choice. It is very unlikely that a participant would be harmed because of participating in the RCT. No new experimental treatments for the patients will be introduced, and care and treatment actions will rely on recommended national care and treatment guidelines. The patients in the control group will receive care and treatment as usual but will probably also profit from the extra attention given by the services because of participation in the RCT.

: The consent form for the patient and their next of kin regarding participation is attached as Additional file . The consent form presented to the participants is in Norwegian, and an English translation of the consent form is included in Additional file .

: The authors declare that they have no competing interests.